Stone Run Capital’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.35M | Sell |
78,195
-45
| -0.1% | -$2.41K | 1.71% | 26 |
|
|
2025
Q2 | $4.03M | Buy |
78,240
+1,956
| +3% | +$98.3K | 1.61% | 32 |
|
|
2025
Q1 | $4.47M | Buy |
76,284
+1,044
| +1% | +$70.7K | 1.88% | 27 |
|
|
2024
Q4 | $5.42M | Sell |
75,240
-1,525
| -2% | -$112K | 2.13% | 24 |
|
|
2024
Q3 | $6.14M | Sell |
76,765
-175
| -0.2% | -$13.2K | 2.28% | 21 |
|
|
2024
Q2 | $5.51M | Sell |
76,940
-3,025
| -4% | -$223K | 2.2% | 23 |
|
|
2024
Q1 | $5.63M | Sell |
79,965
-1,700
| -2% | -$122K | 2.15% | 24 |
|
|
2023
Q4 | $6.3M | Sell |
81,665
-4,670
| -5% | -$308K | 2.7% | 17 |
|
|
2023
Q3 | $5.88M | Sell |
86,335
-1,800
| -2% | -$142K | 2.88% | 16 |
|
|
2023
Q2 | $7.19M | Sell |
88,135
-1,300
| -1% | -$104K | 3.2% | 13 |
|
|
2023
Q1 | $6.64M | Buy |
89,435
+4,375
| +5% | +$337K | 3.17% | 13 |
|
|
2022
Q4 | $7.05M | Sell |
85,060
-3,160
| -4% | -$251K | 3.56% | 11 |
|
|
2022
Q3 | $6.26M | Sell |
88,220
-1,400
| -2% | -$121K | 3.38% | 14 |
|
|
2022
Q2 | $7.77M | Buy |
89,620
+320
| +0.4% | +$30K | 3.91% | 5 |
|
|
2022
Q1 | $9.67M | Buy |
89,300
+100
| +0.1% | +$10.3K | 3.57% | 8 |
|
|
2021
Q4 | $11.5M | Sell |
89,200
-2,400
| -3% | -$294K | 3.73% | 7 |
|
|
2021
Q3 | $11.1M | Sell |
91,600
-13,200
| -13% | -$1.61M | 3.81% | 5 |
|
|
2021
Q2 | $11.8M | Buy |
104,800
+1,200
| +1% | +$126K | 4.16% | 3 |
|
|
2021
Q1 | $9.89M | Sell |
103,600
-5,800
| -5% | -$529K | 3.78% | 5 |
|
|
2020
Q4 | $8.69M | Sell |
109,400
-4,260
| -4% | -$309K | 3.45% | 8 |
|
|
2020
Q3 | $7.04M | Buy |
113,660
+300
| +0.3% | +$19.5K | 3.22% | 12 |
|
|
2020
Q2 | $7.48M | Sell |
113,360
-2,200
| -2% | -$132K | 3.7% | 5 |
|
|
2020
Q1 | $5.48M | Sell |
115,560
-15,728
| -12% | -$787K | 3.14% | 11 |
|
|
2019
Q4 | $7.21M | Sell |
131,288
-4,100
| -3% | -$215K | 3.2% | 11 |
|
|
2019
Q3 | $6.62M | Sell |
135,388
-800
| -0.6% | -$40.1K | 3.16% | 10 |
|
|
2019
Q2 | $7.1M | Sell |
136,188
-1,212
| -0.9% | -$61.1K | 3.24% | 8 |
|
|
2019
Q1 | $6.82M | Sell |
137,400
-1,200
| -0.9% | -$54K | 3.35% | 8 |
|
|
2018
Q4 | $5.01M | Sell |
138,600
-2,400
| -2% | -$100K | 3.12% | 11 |
|
|
2018
Q3 | $7.2M | Sell |
141,000
-8,100
| -5% | -$359K | 3.3% | 6 |
|
|
2018
Q2 | $5.51M | Sell |
149,100
-200
| -0.1% | -$7.64K | 2.91% | 10 |
|
|
2018
Q1 | $5.64M | Sell |
149,300
-10,400
| -7% | -$367K | 2.96% | 10 |
|
|
2017
Q4 | $5.17M | Sell |
159,700
-12,000
| -7% | -$381K | 2.66% | 12 |
|
|
2017
Q3 | $5.19M | Hold |
171,700
| – | – | 2.67% | 13 |
|
|
2017
Q2 | $5.04M | Hold |
171,700
| – | – | 2.79% | 12 |
|
|
2017
Q1 | $4.36M | Hold |
171,700
| – | – | 2.62% | 14 |
|
|
2016
Q4 | $4.41M | Sell |
171,700
-8,700
| -5% | -$229K | 2.87% | 13 |
|
|
2016
Q3 | $4.94M | Sell |
180,400
-200
| -0.1% | -$5.49K | 3.07% | 9 |
|
|
2016
Q2 | $5.09M | Sell |
180,600
-2,000
| -1% | -$51.4K | 3.32% | 8 |
|
|
2016
Q1 | $4.32M | Buy |
+182,600
| New | +$4.02M | 2.78% | 10 |
|
Other funds holding TECH
MC
Stone Run Capital's TECH Position: Q3 2025 in Review
Stone Run Capital reduced its Bio-Techne (TECH) stake by 0.06% in Q3 2025, selling an estimated $2.41K and leaving 78,195 shares worth $4.35M. The position accounts for 1.71% of the portfolio, ranked #26.
Stone Run Capital first reported a position in TECH in Q1 2016 and has held it in 39 quarters since. The position peaked at $11.8M in Q2 2021. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.
- Stone Run Capital held 78,195 shares of Bio-Techne worth $4.35M as of Q3 2025.
- Stone Run Capital sold 45 Bio-Techne shares in Q3 2025, an estimated $2.41K.
- Bio-Techne made up 1.71% of Stone Run Capital's portfolio in Q3 2025, its #26 holding.
- Stone Run Capital first reported a position in Bio-Techne in Q1 2016 and has held it in 39 quarters since.
- Stone Run Capital's Bio-Techne position peaked at $11.8M in Q2 2021.
- 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.
Based on Stone Run Capital's 13F filing for Q3 2025, filed 14 Nov 2025.